Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995 Apr;195(1):86-90.
doi: 10.1148/radiology.195.1.7534429.

Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site

Affiliations
Comparative Study

Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site

J S Newman et al. Radiology. 1995 Apr.

Abstract

Purpose: To correlate the findings at prostate color Doppler sonography (CDS) with those of site-specific transrectal core biopsy.

Materials and methods: Forty-three patients underwent prostate transrectal ultrasonography (US) and biopsy. CDS was performed at all biopsy sites before US-guided core biopsy. Vascularity at CDS was prospectively graded on a scale of 0-2 (0 = no visible peripheral zone [PZ] flow, 2 = markedly increased PZ vascularity). CDS results were correlated with histologic findings from 220 separate biopsy sites that included 27 focal lesions.

Results: Of 34 grade 2 biopsy sites, 21 revealed carcinoma, eight revealed prostatitis, and five were negative. CDS depicted at least one focus of carcinoma in seven patients with no gray-scale abnormality. CDS had a sensitivity of 49%, specificity of 93%, and positive predictive value of 62%.

Conclusion: Focal PZ hypervascularity at CDS is associated with an increased likelihood of prostate cancer or inflammation at biopsy, often without a focal gray-scale abnormality. CDS may help identify an appropriate site for biopsy. A negative CDS scan, however, should not preclude biopsy, as CDS has a limited sensitivity in the detection of all sites of cancer.

PubMed Disclaimer

Comment in

Publication types

Substances

LinkOut - more resources